Cargando…
Patient preferences for allogeneic haematopoietic stem cell transplantation: how much benefit is worthwhile from the patient’s perspective?
Oncological studies have shown that patients consider small benefits sufficient to make adjuvant chemotherapy worthwhile. We sought to determine the minimal survival benefits that patients considered enough to legitimate allogeneic haematopoietic stem cell transplantation (HCT) and the factors assoc...
Autores principales: | Leuthold, Nicolas, Cattaneo, Marco, Halter, Jörg, Hügli, Claudia, Kirsch, Monika, Petropoulou, Anna, Erlanger, Tobias E., Gerull, Sabine, Passweg, Jakob, O’Meara Stern, Alix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062338/ https://www.ncbi.nlm.nih.gov/pubmed/33067766 http://dx.doi.org/10.1007/s00520-020-05816-z |
Ejemplares similares
-
Dissociations of oral foci of infections with infectious complications and survival after haematopoietic stem cell transplantation
por: Mauramo, Matti, et al.
Publicado: (2019) -
Community-Acquired Respiratory Paramyxovirus Infection After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience
por: Spahr, Yasmin, et al.
Publicado: (2018) -
Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates
por: Sava, Mihaela, et al.
Publicado: (2022) -
Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin
por: Stutz, Lina, et al.
Publicado: (2022) -
Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation
por: Shumilov, Evgenii, et al.
Publicado: (2021)